Nov 04 2025
Researchers at the University of the Balearic Islands report that orally administered psilocybin produced rapid and durable antidepressant-like effects in adolescent rats, with changes in brain markers linked to neuroplasticity. The preclinical study, published in Biomedicine & Pharmacotherapy, tested male and female Sprague-Dawley rats and found benefits across both sexes.
Nov 04 2025
Researchers from Harvard Medical School, the Dana-Farber Cancer Institute, and McGill University found that psilocybin-assisted therapy (PAT) can be safely and feasibly integrated into hospice care for terminally ill patients. The findings were published in the peer-reviewed journal BMJ Supportive & Palliative Care.
Nov 03 2025
A study by the University of Iowa and the VA’s Center for the Prevention and Treatment of Visual Loss reports that a CBD–THC mix reduced migraine-like symptoms in an animal model. The study, published in the journal Cephalalgia, tested a 100:1 ratio of cannabidiol (CBD) and tetrahydrocannabinol (THC) on mice, given intraperitoneally before centrally administering …
Nov 03 2025
Researchers from the Korea Atomic Energy Research Institute found that consuming CBD via nanoemulsion dramatically improves absorption and stability compared to traditional oral formulations. The findings were published in ACS Omega. Oral delivery of CBD has long been limited by its poor water solubility and low bioavailability, notes the research team. To address this, they …
Nov 02 2025
A new study published in Fitoterapia found that extracts from Cannabis sativa reduced oxidative stress and the buildup of harmful proteins associated with Parkinson’s disease in cell models. Researchers from Newcastle University and the Federal Rural University of Rio de Janeiro tested four marijuana extracts with varying levels of cannabinoids—THC, CBD, and CBN—on yeast and …
Oct 31 2025
A study published in the South African Journal of Botany found that in an animal model of type 2 diabetes, cannabinoids significantly reduced blood sugar and cholesterol levels while protecting the liver and kidneys. Researchers from Northeast Forestry University and Harbin University of Science and Technology extracted and purified 12 cannabinoid compounds from hemp using …
Oct 30 2025
A study published today in Epilepsia Open provides additional evidence that highly purified CBD can help a wide range of patients with severe epilepsies beyond currently approved conditions. Researchers from Università Cattolica del Sacro Cuore and Azienda Ospedaliero-Universitaria Delle Marche reviewed data from 107 individuals with developmental and epileptic encephalopathies (DEEs) who were treated with …
Oct 30 2025
A large study published in Cancer Medicine has found that medical marijuana can ease anxiety and depression in cancer patients, with outcomes influenced by dosage and method of use. Researchers from the University of Wisconsin-Madison and the Minnesota Office of Cannabis Management analyzed data from 1,962 cancer patients enrolled in the Minnesota Medical Cannabis Program. …
Oct 30 2025
A new study published in the journal Biomedicines has found that inhaled cannabis can provide lasting benefits for patients suffering from painful diabetic neuropathy (DN), a common complication of diabetes that affects up to half of long-term patients. The five-year observational study followed 52 patients who had failed to respond to at least three conventional …
Oct 30 2025
According to a study published in the peer-reviewed journal American Surgeon, there’s no evidence that cannabis use increases the risk of blood clots or alters coagulation-related biomarkers in adolescent and adult trauma patients. For the study, researchers reviewed records of 302 patients admitted to a level one trauma center between October 2019 and December 2023, …
